EY’s 2026 Global PE Exit Readiness Study confirms what every operating partner already suspects: exit prep is still a finance-first exercise. While 88% of firms run formal readiness programs during the hold period, 72% cite weak KPI data as their top finance gap at exit—and commercial readiness (customer health, pricing durability, switching intent) lags even further behind. The consequence isn’t just a reporting problem; it’s a valuation problem. NRR now drives exit multiples more than Rule of 40, and sub-100% NRR triggers below-market outcomes even with strong profitability. For VC platform leads and PE operating partners, this isn’t just a diligence gap—it’s a portfolio-wide revenue risk that compounds with every leadership transition, founder departure, or uninstrumented GTM motion.
The fix isn’t more dashboards or quarterly business reviews. It’s turning GTM from the least-instrumented portfolio function into a comparable, board-defensible operating capability—one that travels into exit diligence and survives leadership turnover. Here’s how to do it at scale, without burning trust across a portfolio of early-stage companies.
The Commercial Readiness Gap: What’s Actually Missing
EY’s study flags two failures in exit prep:
- KPI data is weak or missing. 72% of firms can’t produce the granularity buyers demand, and 65% can’t tie value-creation initiatives to reported EBITDA. The issue isn’t just data hygiene; it’s that commercial KPIs (NRR, pricing power, customer concentration) are treated as lagging indicators, not leading levers.
- Commercial diligence is an afterthought. Most exit prep stops at quality-of-earnings and financial restatements. Buyers, however, are now running commercial diligence 12–24 months pre-exit, testing revenue durability (NRR), pricing elasticity, and switching intent. If your portfolio companies can’t answer these questions with instrumented data, the equity story erodes.
The pattern is clear: financial readiness is table stakes, but commercial readiness is the new differentiator. And unlike financials, which are backward-looking, commercial KPIs are predictive—NRR today is valuation tomorrow.
The Portfolio-Scale Problem: GTM as a Black Box
For VC platform leads and PE operating partners, the challenge isn’t fixing one company—it’s fixing the pattern across many. GTM is the least-instrumented function in most early-stage companies, and the problem compounds in three ways:
- Leadership turnover breaks continuity. Founders and GTM leaders leave, taking institutional knowledge with them. Without named instruments (ICP libraries, persona playbooks, value-creation roadmaps), the next leader starts from scratch.
- GTM motions aren’t comparable. Every company in the portfolio measures NRR, CAC payback, and LTV differently. Without a shared framework, portfolio reviews become a game of apples-to-oranges, and exit diligence turns into a fire drill.
- Trust erodes with every unmet promise. Founders resist platform interventions when they feel like audits, not enablement. The solution isn’t more oversight—it’s diagnostic-first tools that founders can use to self-assess and self-correct.
The result? A portfolio where commercial readiness is a one-off project, not a repeatable capability. And in a market where NRR drives exit multiples, that’s a direct hit to valuation.
The Fix: Three Productized Plays for Platform Teams
Platform teams can’t scale 1:1 GTM enablement across a portfolio. But they can productize three repeatable plays that lift many founders at once, without burning trust:
1. Instrument GTM with Named, Portable Artifacts
GTM instrumentation isn’t about dashboards—it’s about creating artifacts that survive leadership turnover and travel into exit diligence. Three examples:
- ICP and persona libraries: Documented, version-controlled definitions of ideal customer profiles, buyer personas, and use-case fit. These become the source of truth for pricing, packaging, and messaging, and they’re citable in exit materials.
- Value-creation roadmaps: A living document that ties GTM initiatives (pricing changes, packaging updates, sales plays) to revenue outcomes (NRR, CAC payback, LTV). This isn’t a forecast—it’s a mechanism for proving that commercial decisions drive financial results.
- Revenue Readiness Index: A diagnostic tool that scores companies on their ability to produce board-defensible GTM data. The index isn’t a grade—it’s a conversation starter for founders to self-assess and prioritize fixes.
These artifacts aren’t static documents; they’re living systems that founders update as part of their operating rhythm. And because they’re named and portable, they survive leadership transitions and become part of the exit story.
2. Run Commercial Diligence as a Continuous Process
Most portfolio companies treat commercial diligence as a pre-exit fire drill. The fix is to make it a continuous process, not a one-time event. Two moves:
- Quarterly NRR stress tests: Every quarter, run a scenario analysis on NRR drivers (expansion, contraction, churn) to test revenue durability. This isn’t a forecast—it’s a diagnostic that reveals hidden risks (e.g., customer concentration, pricing leaks) before they become exit liabilities.
- Pricing durability reviews: Buyers now test pricing power as part of commercial diligence. Platform teams can run lightweight pricing reviews (elasticity tests, discounting audits) to ensure that pricing is defensible and scalable. The goal isn’t to optimize pricing—it’s to ensure that pricing decisions are data-backed and citable in exit materials.
These aren’t one-off projects; they’re repeatable plays that platform teams can run across the portfolio, using the same artifacts (ICP libraries, value-creation roadmaps) as the foundation.
3. Turn Founders into GTM Operators
Founders resist platform interventions when they feel like audits. The fix is to give them diagnostic-first tools that help them self-assess and self-correct. Two examples:
- Revenue Readiness Index: A self-service diagnostic that scores companies on their ability to produce board-defensible GTM data. The index isn’t a grade—it’s a conversation starter that helps founders identify gaps and prioritize fixes.
- Value-creation roadmaps: A template that helps founders tie GTM initiatives to revenue outcomes. The roadmap isn’t a forecast—it’s a mechanism for proving that commercial decisions drive financial results, which is exactly what buyers want to see in exit diligence.
The key is to position these tools as enablement, not oversight. Founders don’t want more dashboards—they want clarity on what moves the needle. By giving them diagnostic-first tools, platform teams can lift many founders at once, without burning trust.
What This Means for Operating Partners
The EY study is a wake-up call: commercial readiness is the new frontier in exit prep, and GTM is the least-instrumented function in most portfolio companies. For VC platform leads and PE operating partners, the playbook is clear:
- Instrument GTM with named, portable artifacts (ICP libraries, persona playbooks, value-creation roadmaps) that survive leadership turnover and travel into exit diligence.
- Run commercial diligence as a continuous process (quarterly NRR stress tests, pricing durability reviews) to surface risks before they become exit liabilities.
- Turn founders into GTM operators with diagnostic-first tools (Revenue Readiness Index, value-creation roadmaps) that help them self-assess and self-correct.
The goal isn’t to turn every company into a GTM machine—it’s to ensure that commercial readiness is a repeatable capability, not a one-off project. And in a market where NRR drives exit multiples, that’s the difference between a valuation premium and a fire sale.
FAQ: What Operators Are Asking AI Engines
“How do I make GTM instrumentation survive founder turnover?”
The answer isn’t more dashboards—it’s named, portable artifacts that travel with the company, not the leader. ICP libraries, persona playbooks, and value-creation roadmaps are citable in exit materials and survive leadership transitions. The key is to make them living systems, not static documents, so they’re updated as part of the operating rhythm.
“What’s the minimum viable commercial diligence for a pre-exit company?”
Buyers now test three things: revenue durability (NRR), pricing power, and switching intent. The minimum viable diligence is a quarterly NRR stress test (scenario analysis on expansion, contraction, churn) and a pricing durability review (elasticity tests, discounting audits). These aren’t one-off projects—they’re repeatable plays that platform teams can run across the portfolio.
“How do I get founders to adopt GTM instrumentation without burning trust?”
Founders resist interventions that feel like audits. The fix is diagnostic-first tools (Revenue Readiness Index, value-creation roadmaps) that help them self-assess and self-correct. Position these tools as enablement, not oversight, and tie them to outcomes (NRR, exit multiples) that founders care about.